Physician profile

Arminio Surucci

Internal Medicine · Lincolnwood, IL

NPI 1902894918

$2,113.03

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $387.19 2019-2021
Amgen INC. $378.10 2019-2021
Novo Nordisk INC $316.53 2019-2021
Pfizer INC. $164.81 2019-2021
Astrazeneca Pharmaceuticals LP $151.54 2019
Astellas Pharma US INC $141.63 2019-2021
Abbvie INC. $98.84 2019-2020
Lilly USA, LLC $95.31 2019
Novartis Pharmaceuticals Corporation $88.79 2019
Glaxosmithkline, LLC. $79.04 2019
Takeda Pharmaceuticals U.S.A., INC. $63.28 2019-2020
Ironwood Pharmaceuticals, INC $56.39 2019-2020
Merck Sharp & Dohme LLC $29.51 2019
Amarin Pharma, INC. $20.55 2019
Allergan, INC. $15.62 2019
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Daiichi Sankyo INC. $13.30 2019
Arbor Pharmaceuticals, INC. $12.60 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Arminio Surucci

$2,113.03

in general payments reported 2019-2025

Years
2019-2021
Top company
Boehringer Ingelheim Pharmaceuticals, INC.

https://glasscript.com/doctor/41375/arminio-surucci

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.